13F-HR filed by Sofinnova Investments, Inc.
Sofinnova Investments, Inc. filed this 13F-HR for the quarter ended 2018-09-30, filed 2018-11-15, with 61 holding rows worth $1,121,749,000.
- Accession
- 0001144204-18-060046
- Filer
- CIK 1631134
- Filed
- 2018-11-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2018
A holdings report, 144 entries on the cover page, a total value of $1,121,749,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,121,747,000 with VALUE read as thousands by filing date, 13F file number 028-18774. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerCrestline Management, LP028-14917
- included managerBlackstone Alternative Asset Management L.P.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 2,479,514 | $175,698,000 | thousands by filing date | |
| Nucana PLC | GB00BYWYV | COMMON SHARES | 4,000,000 | $99,680,000 | thousands by filing date | |
| ObsEva SA | H5861P103 | COM | 4,749,623 | $85,636,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 5,208,306 | $84,739,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 3,100,560 | $74,227,000 | thousands by filing date | |
| PRINCIPIA BIOPHARMA INC | 74257L108 | COM | 2,059,146 | $59,556,000 | thousands by filing date | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 2,104,278 | $55,890,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 2,868,221 | $47,326,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 1,961,039 | $38,711,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 933,640 | $36,963,000 | thousands by filing date | |
| SPARK THERAPEUTICS INC | 84652J103 | COM | 481,270 | $26,253,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 922,700 | $23,529,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,539,480 | $22,353,000 | thousands by filing date | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 412,746 | $18,438,000 | thousands by filing date | |
| ALLERGAN PLC | G0177J108 | SHS | 96,021 | $18,290,000 | thousands by filing date | |
| NUCANA PLC | 67022C106 | ADR | 666,666 | $16,613,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 336,835 | $15,444,000 | thousands by filing date | |
| ENTASIS THERAPEUTICS HLDGS I | 293614103 | COM | 1,180,178 | $12,840,000 | thousands by filing date | |
| ITERUM THERAPEUTICS PLC SHS NEW | G6333L101 | Stock | 1,726,514 | $11,438,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 3,260,931 | $10,467,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 549,580 | $9,772,000 | thousands by filing date | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 240,608 | $9,520,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 295,589 | $9,356,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 65,360 | $9,085,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 223,675 | $8,725,000 | thousands by filing date | |
| SYNLOGIC INC | 87166L100 | COM | 574,972 | $8,170,000 | thousands by filing date | |
| SAVARA INC | 805111101 | COM | 698,225 | $7,793,000 | thousands by filing date | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 193,400 | $7,652,000 | thousands by filing date | call |
| EXELIXIS INC COM | 30161Q104 | Stock | 403,594 | $7,151,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 69,615 | $6,946,000 | thousands by filing date | |
| ADAMAS PHARMACEUTICALS INC | 00548A106 | COM | 345,756 | $6,922,000 | thousands by filing date | |
| AIMMUNE THERAPEUTICS INC. | 00900T107 | Common Stock | 222,295 | $6,064,000 | thousands by filing date | |
| CHIASMA INC | 16706W102 | COM | 1,767,102 | $5,869,000 | thousands by filing date | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 1,549,552 | $5,858,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 495,293 | $5,399,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 445,969 | $5,392,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 1,842,502 | $5,152,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 133,066 | $4,996,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 29,915 | $4,832,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 159,302 | $4,646,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 247,385 | $4,329,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 51,339 | $4,008,000 | thousands by filing date | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 668,619 | $3,832,000 | thousands by filing date | |
| CLEARSIDE BIOMEDICAL INC | 185063104 | COM | 606,914 | $3,732,000 | thousands by filing date | |
| MOLECULAR PARTNERS AG -ADR | H55351102 | ADR | 144,960 | $3,248,000 | thousands by filing date | |
| Morphosys | D55040105 | COM | 30,000 | $3,208,000 | thousands by filing date | |
| CONATUS PHARMACEUTICALS INC | 20600T108 | COM | 538,915 | $3,126,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 291,318 | $3,087,000 | thousands by filing date | |
| OTONOMY INC | 68906L105 | COM | 987,778 | $2,716,000 | thousands by filing date | |
| EDGE THERAPEUTICS INC | 279870109 | COM | 2,852,711 | $2,339,000 | thousands by filing date | |
| SPRING BK PHARMACEUTICALS IN | 849431101 | COM | 189,646 | $2,285,000 | thousands by filing date | |
| ARQULE INC | 04269E107 | COM | 386,271 | $2,187,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 104,891 | $1,709,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 36,599 | $1,624,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 173,112 | $1,398,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC. | 00739L101 | Common Stock | 189,579 | $1,393,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 89,919 | $1,220,000 | thousands by filing date | |
| Ocugen | 43358V109 | Common | 2,077,040 | $1,132,000 | thousands by filing date | |
| KALA BIO INC COM | 483119103 | Stock | 95,655 | $944,000 | thousands by filing date | |
| ONCOMED PHARMACEUTICALS INC COM | 68234X102 | Stock | 395,744 | $839,000 | thousands by filing date | |
| AURIS MED HLDG AG | H0381L104 | COM | 140,000 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-18-060046 | this filing | 2018-11-15 | acceptance time not in the bulk data set |